Neupogen (filgrastim, G-CSF) to treat diabetic foot infections

December 1997

    Researchers are now trying Neupogen (filgrastim, G-CSF) to treat diabetic foot infections.

    This is very preliminary...but initial results look promising.

    Neupogen is usually given to increase the PRODUCTION of neutrophils. In this situation, it's used to improve their FUNCTION.

Upgrade now for access to this resource

This content is not available under the subscriptions purchased by your organization, but you can add it on!

Prescriber Insights: APRN includes

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations